Table 1

JAK2-V617F genotyping of iPS cell lines derived from MPD patients

Cells analyzedWild-type allele (1849G), percentageV617F allele (1849T), percentage
CD34+ cells from MPD183 48 52 
    iPS MPD183 clone 1 46 54 
    iPS MPD183 clone 2 45 55 
    iPS MPD183 clone 3 48 52 
    iPS MPD183 clone 5 46 54 
    iPS MPD183 clone 6 45 55 
    iPS MPD183 clone 7 46 54 
    iPS MPD183 clone 8 46 54 
    iPS MPD183 clone 10 47 54 
    iPS MPD183 clone 11 50 50 
CD34+ cells from MPD562 50 50 
    iPS MPD562 clone 2 46 54 
    iPS MPD562 clone 3 49 51 
Cells analyzedWild-type allele (1849G), percentageV617F allele (1849T), percentage
CD34+ cells from MPD183 48 52 
    iPS MPD183 clone 1 46 54 
    iPS MPD183 clone 2 45 55 
    iPS MPD183 clone 3 48 52 
    iPS MPD183 clone 5 46 54 
    iPS MPD183 clone 6 45 55 
    iPS MPD183 clone 7 46 54 
    iPS MPD183 clone 8 46 54 
    iPS MPD183 clone 10 47 54 
    iPS MPD183 clone 11 50 50 
CD34+ cells from MPD562 50 50 
    iPS MPD562 clone 2 46 54 
    iPS MPD562 clone 3 49 51 
Close Modal

or Create an Account

Close Modal
Close Modal